Ken Griffin Foghorn Therapeutics Inc. Put Options Transaction History

Citadel Advisors LLC

  • $505 Billion
  • Q3 2024

Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$4.8 - $9.99 $2,880 - $5,994
600 Added 33.33%
2,400 $22,000
Q2 2024

Aug 14, 2024
BUY
$5.05 - $8.0 $2,020 - $3,200
400 Added 28.57%
1,800 $10,000
Q1 2024

May 15, 2024
BUY
$2.82 - $7.94 $3,948 - $11,116
1,400 New
1,400 $9,000
Q1 2023

May 15, 2023
BUY
$4.66 - $8.99 $2,330 - $4,495
500 Added 21.74%
2,800 $17,000
Q4 2022

Feb 14, 2023
BUY
$5.44 - $9.46 $12,512 - $21,758
2,300 New
2,300 $14,000

Others Institutions Holding FHTX

# of Institutions
80
Shares Held
33.3M
Call Options Held
8.7K
Put Options Held
2.4K
View Full List

About Foghorn Therapeutics Inc.

FHTX Quotes by TradingView
  • Ticker FHTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,637,400
  • Market Cap $313M
  • Description
  • Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...
More about FHTX
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email